sodium chloride

Generic: sodium chloride

Labeler: fresenius kabi usa, llc
NDC Directory HUMAN PRESCRIPTION DRUG UNAPPROVED DRUG OTHER Inactive Finished

Drug Facts

Product Profile

Brand Name sodium chloride
Generic Name sodium chloride
Labeler fresenius kabi usa, llc
Dosage Form INJECTION, SOLUTION
Routes
INTRAVENOUS
Active Ingredients

sodium chloride 146 mg/mL

Manufacturer
Fresenius Kabi USA, LLC

Identifiers & Regulatory

Product NDC 63323-139
Product ID 63323-139_64f0e9ba-8a8e-44f8-9d5b-763ed482f84d
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category UNAPPROVED DRUG OTHER
Listing Expiration 2026-12-31
Marketing Start 2000-09-06

Pharmacologic Class

Classes
increased large intestinal motility [pe] inhibition large intestine fluid/electrolyte absorption [pe] osmotic activity [moa] osmotic laxative [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 63323139
Hyphenated Format 63323-139

Supplemental Identifiers

RxCUI
1807580
UPC
0363323139407
UNII
451W47IQ8X

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name sodium chloride (source: ndc)
Generic Name sodium chloride (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 146 mg/mL
source: ndc
Packaging
  • HOW SUPPLIED Sodium Chloride Injection, USP is available in flip-top glass vials. Product No. NDC No. % NaCl Na + mEq/mL Cl - mEq/mL mOsmol/ mL Fill Volume mL 13920 63323-139-20 14.6 2.5 2.5 5 20 13940 63323-139-40 14.6 2.5 2.5 5 40 These vials are Single Dose Vials; packaged 25 vials per tray. Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Do not permit to freeze.
  • PACKAGE LABEL - PRINCIPAL DISPLAY - Sodium Chloride 40 mL Vial Label NDC 63323-139-40 13940 Sodium Chloride Injection, USP Concentrated 14.6% (2.5 mEq/mL) For IV Use Only After Dilution Rx only 40 mL Single Dose Vial nacl-label-01.jpg
source: label

Packages (0)

No package records.

Ingredients (1)

sodium chloride (146 mg/mL)

Linked Drug Pages (1)

Sodium Chloride ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "64f0e9ba-8a8e-44f8-9d5b-763ed482f84d", "openfda": {"upc": ["0363323139407"], "unii": ["451W47IQ8X"], "rxcui": ["1807580"], "spl_set_id": ["ef09b4e7-ccc5-41c8-ba66-beb7a56d2e67"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [], "brand_name": "Sodium Chloride", "product_id": "63323-139_64f0e9ba-8a8e-44f8-9d5b-763ed482f84d", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Increased Large Intestinal Motility [PE]", "Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]", "Osmotic Activity [MoA]", "Osmotic Laxative [EPC]"], "product_ndc": "63323-139", "generic_name": "SODIUM CHLORIDE", "labeler_name": "Fresenius Kabi USA, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Sodium Chloride", "active_ingredients": [{"name": "SODIUM CHLORIDE", "strength": "146 mg/mL"}], "marketing_category": "UNAPPROVED DRUG OTHER", "marketing_start_date": "20000906", "listing_expiration_date": "20261231"}